Exelixis, Inc. (EXEL)
NASDAQ: EXEL · Real-Time Price · USD
46.26
+1.61 (3.61%)
At close: May 15, 2025, 4:00 PM
46.60
+0.34 (0.73%)
After-hours: May 15, 2025, 7:57 PM EDT

Exelixis Market Cap

Exelixis has a market cap or net worth of $12.62 billion as of May 15, 2025. Its market cap has increased by 75.56% in one year.

Market Cap
12.62B
Enterprise Value
11.15B
1-Year Change
75.56%
Ranking
Category
Stock Price
$46.26

Market Cap Chart

Since April 17, 2000, Exelixis's market cap has increased from $630.80M to $12.62B, an increase of 1,899.92%. That is a compound annual growth rate of 12.68%.

History

DateMarket Cap% Change
May 13, 202510.08B5.96%
Dec 31, 20249.51B27.47%
Dec 29, 20237.46B44.19%
Dec 30, 20225.17B-10.54%
Dec 31, 20215.78B-7.11%
Dec 31, 20206.23B16.30%
Dec 31, 20195.35B-8.96%
Dec 31, 20185.88B-34.61%
Dec 29, 20178.99B110.58%
Dec 30, 20164.27B233.29%
Dec 31, 20151.28B355.89%
Dec 31, 2014281.10M-75.11%
Dec 31, 20131.13B34.59%
Dec 31, 2012839.00M36.62%
Dec 30, 2011614.10M-31.37%
Dec 31, 2010894.80M13.07%
Dec 31, 2009791.40M49.29%
Dec 31, 2008530.10M-41.23%
Dec 31, 2007902.00M4.64%
Dec 29, 2006862.00M10.08%
Dec 30, 2005783.10M10.19%
Dec 31, 2004710.70M41.83%
Dec 31, 2003501.10M9.05%
Dec 31, 2002459.50M-44.16%
Dec 31, 2001822.90M25.02%
View and export this data all the way back to 2000. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 640.72B
Johnson & Johnson 358.00B
AbbVie 313.34B
Novo Nordisk 288.64B
Abbott Laboratories 229.92B
UnitedHealth Group 228.64B
Novartis AG 208.47B
AstraZeneca 206.71B
Market Cap Rankings